ARTICLE | Company News
Consensus Pharmaceuticals Inc. other research news
April 3, 2000 7:00 AM UTC
Consensus received a $99,000 Phase I SBIR grant from the National Institute of Allergy and Infectious Diseases to develop peptides against the CCR5 coreceptor that prevent HIV infection of macrophages...